Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey A Block

Showing results (21-30 of 117) with videos related to

Pageof 12
Sort By:
The American Journal of Clinical Nutrition|October 22, 2014
Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover studyJoachim H Ix, Cheryl A M Anderson, Gerard Smits, et al.
International Journal of Nephrology|December 22, 2011
Patterns of Hemodialysis Catheter Dysfunction Defined According to National Kidney Foundation Guidelines As Blood Flow <300 mL/minRobert I Griffiths, Britt B Newsome, Geoffrey A Block, et al.
Kidney International|September 17, 2005
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysisGeoffrey A Block, David M Spiegel, James Ehrlich, et al.
BMC Surgery|December 1, 2016
Geographic variation of parathyroidectomy in patients receiving hemodialysis: a retrospective cohort analysisJames B Wetmore, Jiannong Liu, Paul J Dluzniewski, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 5, 2018
The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemiaGeoffrey A Block, David P Rosenbaum, Andrew Yan, et al.
Plos One|November 30, 2017
Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney diseaseGlenn M Chertow, Geoffrey A Block, John F Neylan, et al.
Journal of the American Society of Nephrology : JASN|January 14, 2017
Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency AnemiaSteven Fishbane, Geoffrey A Block, Lisa Loram, et al.
Plos One|March 16, 2019
An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidismGeoffrey A Block, Glenn M Chertow, John T Sullivan, et al.
Journal of the American Society of Nephrology : JASN|July 7, 2019
A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKDGeoffrey A Block, Martha S Block, Gerard Smits, et al.
Journal of the American Society of Nephrology : JASN|July 31, 2004
Mineral metabolism, mortality, and morbidity in maintenance hemodialysisGeoffrey A Block, Preston S Klassen, J Michael Lazarus, et al.
Pageof 12

Showing results (21-30 of 117) with videos related to

Sort By:
Pageof 12
The American Journal of Clinical Nutrition|October 22, 2014
Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover studyJoachim H Ix, Cheryl A M Anderson, Gerard Smits, et al.
International Journal of Nephrology|December 22, 2011
Patterns of Hemodialysis Catheter Dysfunction Defined According to National Kidney Foundation Guidelines As Blood Flow <300 mL/minRobert I Griffiths, Britt B Newsome, Geoffrey A Block, et al.
Kidney International|September 17, 2005
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysisGeoffrey A Block, David M Spiegel, James Ehrlich, et al.
BMC Surgery|December 1, 2016
Geographic variation of parathyroidectomy in patients receiving hemodialysis: a retrospective cohort analysisJames B Wetmore, Jiannong Liu, Paul J Dluzniewski, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 5, 2018
The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemiaGeoffrey A Block, David P Rosenbaum, Andrew Yan, et al.
Plos One|November 30, 2017
Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney diseaseGlenn M Chertow, Geoffrey A Block, John F Neylan, et al.
Journal of the American Society of Nephrology : JASN|January 14, 2017
Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency AnemiaSteven Fishbane, Geoffrey A Block, Lisa Loram, et al.
Plos One|March 16, 2019
An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidismGeoffrey A Block, Glenn M Chertow, John T Sullivan, et al.
Journal of the American Society of Nephrology : JASN|July 7, 2019
A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKDGeoffrey A Block, Martha S Block, Gerard Smits, et al.
Journal of the American Society of Nephrology : JASN|July 31, 2004
Mineral metabolism, mortality, and morbidity in maintenance hemodialysisGeoffrey A Block, Preston S Klassen, J Michael Lazarus, et al.
Pageof 12